Go to Top

Iproteos, devoted to peptidomimetics

The company focuses its activity on the R&D of new therapeutic strategies based on modulation of protein-ligand (PLI) and protein-protein interactions (PPIs) through peptidomimetics. The novel entities are obtained thanks to the IPRO technology, an innovative platform.

Specifically, at Iproteos we apply the IPRO technology on the search for therapeutic agents for the treatment of diseases of the central nervous system (CNS).

Based on our expertise in the field, Iproteos is your perfect partner in the discovery of potent and active peptidomimetics for your own targets.



Iproteos is continuously expanding its partner and collaborator network in order to maximize the scientific and financial support.